Not checked for notices yet.

Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study

Xin Xu, Sheng Nie, Yanqun Wang and 11 more

Signal Transduction and Targeted Therapy · 2021

doi:10.1038/s41392-021-00611-6

References 14

1.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
2.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
3.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
4.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
5.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
6.
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses · 2020
Corrected
7.
DNA vaccine protection against SARS-CoV-2 in rhesus macaques · 2020
No notice
8.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
9.
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients · 2020
No notice
10.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
11.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
12.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
13.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
14.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.